MIRA INFORM REPORT

 

 

Report Date :

14.02.2014

 

IDENTIFICATION DETAILS

 

Name :

P.T. SRI AMAN CORPORINDO

 

 

Registered Office :

Mutiara Taman Palem Block D-8 No. 63 A – 65, Jalan Outer Ring Road, Kelurahan Cengkareng Timur, Kecamatan Cengkareng Jakarta Barat, 11730

 

 

Country :

Indonesia

 

 

Date of Incorporation :

18.03.2008

 

 

Com. Reg. No.:

AHU-AH.01.10-24507

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Trader, Importer, Wholesales and Distributor of Raw Materials from Pharmaceutical, Food, Feed, Cosmetics and Chemical Industries

 

 

No of Employees :

28 Persons

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – december 01, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

Indonesia

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDONESIA - ECONOMIC OVERVIEW

 

Indonesia, a vast polyglot nation, grew more than 6% annually in 2010-12. The government made economic advances under the first administration of President YUDHOYONO (2004-09), introducing significant reforms in the financial sector, including tax and customs reforms, the use of Treasury bills, and capital market development and supervision. During the global financial crisis, Indonesia outperformed its regional neighbors and joined China and India as the only G20 members posting growth in 2009. The government has promoted fiscally conservative policies, resulting in a debt-to-GDP ratio of less than 25%, a fiscal deficit below 3%, and historically low rates of inflation. Fitch and Moody's upgraded Indonesia's credit rating to investment grade in December 2011. Indonesia still struggles with poverty and unemployment, inadequate infrastructure, corruption, a complex regulatory environment, and unequal resource distribution among regions. The government in 2013 faces the ongoing challenge of improving Indonesia's insufficient infrastructure to remove impediments to economic growth, labor unrest over wages, and reducing its fuel subsidy program in the face of high oil prices.

 

Source : CIA

 

 

BASIC SEARCH

 

Name of Company :

 

P.T. SRI AMAN CORPORINDO

 

Address :

 

Head Office

Mutiara Taman Palem Block D-8 No. 63 A - 65

Jalan Outer Ring Road

Kelurahan Cengkareng Timur, Kecamatan Cengkareng

Jakarta Barat, 11730

Indonesia

Phones             - (62-21) 54350781 – 83

Fax                   - (62-21) 54350784

E-mail               - info@simanco.co.id

Website            - http://www.simanco.co.id

Building Area     - 2 storey

Office Space      - 230 sq. meters

Region              - Commercial

Status               - Owned

 

Date of Incorporation :

 

a.   6 February 1968 as P.T. SRI AMAN CORPORATION

b.   18 March 2008 as P.T. SRI AMAN CORPORINDO

 

 

Legal Form :

 

P.T. (Perseroan Terbatas) or Limited Liability Company

 

Company Reg. No. :

 

The Ministry of Law and Human Rights

- No. Y.A.5/114/2

  Dated 24 March 1973

- No. AHU-19446.AH.01.02.TH.2008

  Dated 18 April 2008

- No. AHU-AH.01.10-24507

  Dated 18 June 2013

 

Company Status :

 

National Private Company

 

Permit by the Government Department :

 

The Department of Finance

NPWP No. 01.302.612.5-034.000

 

 

Related Company :

 

None

 

 

CAPITAL AND OWNERSHIP

 

Capital Structure :

Authorized Capital                            : Rp. 1,000,000,000.-

Issued Capital                                  : Rp. 1,000,000,000.-

Paid up Capital                                : Rp. 1,000,000,000.-

 

Shareholders/Owners :

 

a. Mrs. Merie Yanti                                                           - Rp. 350,000,000.-

    Address : Jl. Kembang Indah III G1/23, RT. 007 RW. 006

                    Kelurahan Kembangan Selatan, Kecamatan

                    Kembangan, Jakarta Barat

                    Indonesia

 

b. Mr. Irsan Ridjab                                                            - Rp. 300,000,000.-

    Address : Jl. Pantai Kuta IV/20, RT. 04 RW. 010

                    Kelurahan Ancol, Kecamatan Pademangan

                    Jakarta Utara

                    Indonesia

 

c. Mr. Christovorus Suharyanto Nicolaus                - Rp. 200,000,000.-

    Address : Jl. Kembang Indah III G1/23, RT. 007 RW. 006

                    Kelurahan Kembangan Selatan, Kecamatan

                    Kembangan, Jakarta Barat

                    Indonesia

 

d. Mr. Petrus Tanswari                                                      - Rp. 150,000,000.-

    Address : Villa Tomang Mas C/3, RT. 004 RW. 011

                    Kelurahan Duri Kepa, Kecamatan Kebon

                    Jeruk, Jakarta Barat

                    Indonesia

 

 

BUSINESS ACTIVITIES

 

Lines of Business :

 

Trading, Importer, Wholesales and Distribution of Raw Materials from Pharmaceutical, Food, Feed, Cosmetics and Chemical Industries

 

 

Production Capacity :

 

None

 

 

Total Investment :

 

None

 

 

Started Operation :

 

1968

 

 

Brand Name :

 

Srimanco

 

 

Technical Assistance :

 

None

 

 

Number of Employee :

 

28 persons

 

 

Marketing Area :

 

Local       - 100%

 

 

Main Customer :

 

Pharmaceutical Industries, Cosmetic Industries, Food Processing, and others

 

 

Market Situation :

 

Very Competitive

 

 

Main Competitors :

 

a. P.T. ADIMITRA PRIMA LESTARI

b. P.T. ELANG KURNIA SAKTI

c. P.T. MEGA KEMIRAYA

d. P.T. MENDJANGAN SAKTI

e. P.T. TIRTA WANA SEMESTA KENCANA

 

 

Business Trend :

 

Growing

 

 

BANKER, AUDITOR & LITIGATION

 

Bankers :

 

a.   P.T. Bank CENTRAL ASIA Tbk

      Jalan Outer Ring Road

      Jakarta Barat

      Indonesia

 

b.   P.T. Bank PANIN Tbk

      Jalan Kopi No. 52

      Jakarta Barat

      Indonesia

 

c.   P.T. Bank PERMATA Tbk

      Jalan Prapatan No. 50

      Jakarta Pusat

      Indonesia

 

Auditor :

 

Internal Auditor

 

Litigation :

 

No litigation record in our database

 

 

 

FINANCIAL FIGURE

 

Annual Sales (estimated) :

 

2011 – Rp. 32.0 billion

2012 – Rp. 34.0 billion

2013 – Rp. 36.0 billion

 

 

Net Profit (estimated) :

 

2011 – Rp. 2.0 billion

2012 – Rp. 2.2 billion

2013 – Rp. 2.5 billion

 

 

Payment Manner :

 

Average

 

 

Financial Comments :

 

Satisfactory

 

 

KEY EXECUTIVES

 

Board of Management :

 

President Director                            - Mr. Christovorus Suharyanto Nicolaus

Director                                           - Mr. Petrus Tanswari

 

Board of Commissioners :

 

President Commissioner                   - Mr. Irsan Ridjab

Commissioner                                 - Mrs. Merie Yanti

 

Signatories :

 

President Director (Mr. Christovorus Suharyanto Nicolaus) or the Director (Mr. Petrus Tanswari) which must be approved by Board of Commissioner

 

 

CAPABILITIES

 

Management Capability :

 

Good

 

 

Business Morality :

 

Good

 

Credit Risk :

 

Average

 

 

Credit Recommendation :

 

Credit should be proceeded with monitor

 

 

 

OVERALL PERFORMANCE

 

Originally named P.T. SRI AMAN CORPORATION was established in Jakarta on February 6, 1968 with an authorized capital of Rp. 5,000,000 issued capital of Rp. 1,200,000 fully paid up. The founders and original shareholders of the company were Mr. Jusuf Effendy, Mr. Widjajarto Jachja and Mr. Tirta Jusman, all Indonesian businessmen of Chinese origin. The company notary deed had been changed a couple of times. In April 1980, the whole of its original shareholders pulled out and then replaced by Mr. Drs. Tjahjo Hartono, also an Indonesian businessman of Chinese origin.  In June 2007 P.T. ROTAPRIMA JAYA merged to P.T. SRI AMAN CORPORATION (surviving company). Then on March 2008, Mr. Drs. Tjahjo Hartono pulled out and replaced by Mr. Christovorus Suharyanto Nicolaus, his wife mother Mrs. Merie Yanti, Mr. Irsan Ridjab and Mr. Petrus Tanswari, they are Indonesian businessmen of Chinese origin. Concurrently the company’s name changed to P.T. SRI AMAN CORPORINDO (P.T. SAC) and the authorized capital was raised to Rp 1,000,000,000 entirely issued and paid up. With this development the composition of its shareholders has been changed to become Mrs. Merie Yanti (35%) her husband Mr. Christovorus Suharyanto Nicolaus (20%), Mr. Irsan Ridjab (30%) and Mr. Peturs Tanswari (15%). Later according to the latest revision of notary deed Mr. I Nyoman Pageh, SH., No. 51 dated 30 May 2013 the company board of directors and the board of commissioner re-elected to lead and runs of the company’s operation. The deed of amendments was approved by the Ministry of Law and Human Rights in its decision letter No. AHU-AH.01.10-24507 dated June 18, 2013.

 

P.T. SAC had been operating since 1968 in trading, import, wholesales and distribution of raw materials from pharmaceutical, cosmetic, food, feed, and chemical industries. It was all started with friendship back in 1968. A group of young entrepreneurs formed a traditional medicine distributor. There were many ups and downs during these foundation years before they finally decided to establish a private trading company in 1971. And at the same time, the company also held an official license from the National Agency of Drug and Food Control and Health Ministry to distribute finished formulation. Later in 1979, as the company grew and learned the rope, the management caught a glimpse of an opportunity to expand their business in raw materials. It was not merely a gut factor, but through a long observation, especially when the marketing team went to various places outside Jakarta to promote and distribute the merchandises. There were many local finished formulators in Semarang area and Surabaya area, which were not quite attended by the raw material traders in Jakarta. For that reason, the company applied for an official license to keep stock and distribute raw materials of pharmaceutical and received an approval in that year as well.

 

After economic turmoil of financial crisis that hit Indonesia in 1998, the company still managed to survive. Nevertheless, the management at that time also realized that they needed new investors to enlarge and strengthen its business. Finally in 2000, after looking for the right partner, the company was acquired. New strategy was implemented; however, the value and heritage of the company are still remained. In the past, the management only focused on the bulk commodity products (such as Acetaminophen, Analgin, Caffeine, etc.). But now, the management also pursued high value advanced products as well. The whole products imported from DIVIS LABORATORIS LTD., of the USA; HETERO, HILDOSE and PIRAMAL HEALTHCARE all of India; ILDONG and YUNGJIN both are of South Korea; JW PHARM of China; LINARIA CHEMICAL of Thailand; and TRANSCO PHARMA of Germany.

 

Mr. Petrus Tanswari, director of the company said that the products sold to pharmaceutical industries in the country like P.T. KIMIA FARMA Tbk., P.T. INDOFARMA Tbk., P.T. SANBE FARMA, P.T. KALBE FARMA Tbk., P.T. DEXA MEDICA, etc. We observed that P.T. SAC is classified as a small sized company of its kind in the country of which the operation has been growing and running smoothly within the last three years.

 

Generally, demand for laboratory and medical equipment and various pharmaceutical products had been growing in the last five years up to the end 2012 as pictured in sales value of national pharmaceutical products, import value and export value issued by the Food and Drug Controlling Board (BPOM). The national pharmaceutical sales, export and import value of products are estimated to be rising by 6% to 8% in the next year. The competition is very tight on account many similar companies operating in the country. The business position of P.T. SAC is a sufficiently fairly good because the company has captive market namely the state-owned hospital and private hospital in the country. According the BPOM that national pharmaceutical sales as shown are as the following table.

 

National Market Trend of Drugs, 2001-2012* (Billion Rupiah)

 

Year

Total Market

Ethical Drugs

Generic Drugs

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012*

12.850

15.483

17.458

20.872

23.629

23.173

25.600

29.981

33.965

37.531

43.081

45.235

  7.891

  9.618

10.829

12.706

14.675

13.834

13.959

16.969

19.225

21.142

23.506

25.281

1.547

1.694

1.819

2.136

2.529

2.390

2.295

3,213

3.420

3.610

3.900

4.095

                                               

 

Until this time P.T. SAC has not been registered with Indonesian Stock Exchange, so that they had not obliged to announce their financial statement. The management of P.T. SAC is very reclusive towards outsiders and rejected to disclose its financial condition. We observed that total sales turnover of the company in 2011 amounted to Rp. 32.0 billion rose to Rp. 34.0 billion in 2012 increased to Rp. 36.0 billion in 2013 and projected to go on rising by at least 6% in 2014. The operation in 2013 yielded an estimated net profit of at least Rp. 2.5 billion and the company has an estimated total networth of at least Rp. 7.0 billion. So far, we did not heard that the company having been black listed by the Central Bank (Bank Indonesia). The company usually pays its debts punctually to suppliers.  

 

The management of P.T. SAC is headed by Mr. Christovorus Suharyanto Nicolaus (36) a businessman and professional manager with experience in trading, import, wholesales and distribution of raw materials for pharmaceutical, food, feed, cosmetic and chemical industries. Daily activity he is assisted by Mr. Petrus Tanswari (60) as Director.

 

 

The company's management is handled by professional staff in the above business. They have wide relations with private businessmen within and outside the country. So far, we did not hear that the management of the company being filed to the district court for detrimental cases or involved in any business malpractices. The company’s litigation record is clean and it has not registered with the black list of Bank of Indonesia. P.T. SRI AMAN CORPORINDO is sufficiently fairly good for business transaction.

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 62.27

UK Pound

1

Rs. 103.46

Euro

1

Rs. 84.87

 

 

INFORMATION DETAILS

 

Report Prepared by :

DPT

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.